Jorge Ignacio González Borroto

Jorge Ignacio González Borroto

Auto-generated profile, based on publicly available information

Jorge Ignacio González Borroto

Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Ciències, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2007 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
AGAntonio Guzmán
Antonio Guzmán
AHAntonio R. Fernández de Henestrosa
Antonio R. Fernández de Henestrosa
AMAna-Paz Marín
Ana-Paz Marín
AHAhn Ho
Ahn Ho
JBJorge I. González Borroto
Jorge I. González Borroto
LPLincoln Pritchard
Lincoln Pritchard

7 April 2005 in Mutagenesis
Verified
Journal Article
Open access
PDF file
JBJorge I. González Borroto
Jorge I. González Borroto
GMGiselle Pérez Machado
Giselle Pérez Machado
ACAmadeu Creus
Amadeu Creus
RMRicard Marcos
Ricard Marcos
The genotoxicity of three 2-furylethylene derivatives and four 5-nitrofurans was evaluated by using the comet assay in human lymphoblastoid cultured TK6 cells. The 2-furylethylene derivatives were 2-furyl-1-nitroethene, 1-(5-bromofur-2-yl)-2-nitroethene and 1-(5-bromofur-2-yl)-2-bromo-2-nitroethene, while the 5-nitrofurans were nitrofurantoin, nitrofurazone, furazolidone and 5-nitro-2-furanacrolein. The treatments lasted for 3 h in the absence of metabolic activation. No genotoxic effects were observed for two of the 2-furylethylene compounds, while the derivative 1-(5-bromofur-2-yl)-2-nitroethene showed a statistically significant response mainly at the highest concentration tested; this effect was considered biologically relevant and the compound was classified as slightly genotoxic. On the other hand, for the classical 5-nitrofurans tested there is a tendency towards a dose-related increase of the DNA damage in the comet assay and the observed increases for the parameters analysed (Olive tail moment, tail % DNA and tail length) were significant for all compounds. Then, the four 5-nitrofurans tested were considered genotoxic. These results show that the position of the nitro group influences the genotoxicity of the assayed compounds. Thus, in this comet assay, the 2-furylethylene derivatives having the nitro group attached outside the furan ring appear to be much less genotoxic than the 5-nitrofurans.

7 March 2003 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
JBJorge I Gonzalez Borroto
Jorge I Gonzalez Borroto
ACAmadeu Creus
Amadeu Creus
RMRicard Marcos
Ricard Marcos
RMRicard Molla
Ricard Molla
JZJorge Zapatero
Jorge Zapatero
The compound 2-furyl-1-nitroethene (G-0) has been tested to determine its ability to induce clastogenic or aneugenic effects in vivo, through the induction of micronucleated polychromatic erythrocytes (MNPCE) in mouse bone marrow. Groups of five CD-1 male mice were administered once intraperitoneally at a dose range of 5–20 mg/kg and bone marrow was sampled at 24 and 48 h after the treatment. G-0 was dissolved in corn oil, thus a vehicle control group received only corn oil at 10 ml/kg. The positive control group was administered with cyclophosphamide (40 mg/kg). All animals dosed with the highest concentration of the test agent (20 mg/kg) showed evident clinical symptoms of toxicity. Although evidences of bone marrow toxicity were observed, no statistically significant increases in the incidence of MNPCE over the vehicle control group were observed at any sampling time with any of the assayed doses of the G-0 compound. Cyclophosphamide treatment increased the incidence of MNPCE in all treated animals, demonstrating the sensitivity of the assay conditions in which it was carried out. From the results obtained, it is concluded that the test agent G-0 is neither clastogenic nor aneugenic in the erythrocytes from the bone marrow of treated mice at the doses tested.

1 January 2004 in Mutagenesis
Verified
Journal Article
Open access
PDF file
GMGiselle Pérez Machado
Giselle Pérez Machado
JBJorge I. González Borroto
Jorge I. González Borroto
NCNilo Castañedo
Nilo Castañedo
ACAmadeu Creus
Amadeu Creus
RMRicard Marcos
Ricard Marcos
The possible genotoxic potential of the 2‐furylethylene derivative UC‐245 has been evaluated in vitro using human cells as a test system. This compound was synthesized at the Centro de Bioactivos Químicos, Universidad Central de Las Villas (Cuba) and it appears to be effective against leishmaniosis. The induced genetic damage was determined by scoring the frequency of micronuclei (MN) and the frequency of sister chromatid exchanges (SCE) in primary lymphocyte cultures set up from two different donors. The DNA breakage level was also evaluated by the Comet assay, using an established human lymphoblastoid cell line (TK6). For the MN and SCE studies, to detect eventual metabolic modification in the genotoxicity of this compound, the cultures were treated with S9 microsomal fraction. The results obtained indicate that, under the experimental conditions used, the test agent does not induce significant increases in the frequency of micronucleated cells, irrespective of presence/absence of the metabolic fraction, which would indicate a lack of clastogenic and/or aneugenic potential. Nevertheless, a clear and significant increase in the SCE frequency was observed in the treatments without S9. This would support the 2‐furylethylene derivative UC‐245 inducing DNA primary damage. In addition, the results obtained in the Comet assay also show that UC‐245 induces a significant increase in the level of DNA breakage, which would confirm its genotoxicity.

10 May 2018 in Future Microbiology
Verified
Journal Article
Closed access
JBJorge Ignacio González Borroto
Jorge Ignacio González Borroto
MAMalaika Sharon Awori
Malaika Sharon Awori
LCLuc Chouinard
Luc Chouinard
SSSusan Y Smith
Susan Y Smith
CTCristina Tarragó
Cristina Tarragó
IZIlonka Zsolt
Ilonka Zsolt
Aim: Ozenoxacin is a nonfluorinated quinolone antibacterial approved for topical treatment of impetigo. Because quinolones have known chondrotoxic effects in juvenile animals, the potential toxicity of ozenoxacin was assessed in preclinical studies. Materials & methods: Ozenoxacin or ofloxacin (300 mg/kg/day for 5 days, for each compound) was orally administered to juvenile rats, and oral ozenoxacin (10–100 mg/kg/day for 14 days) was administered to juvenile dogs. Results: In juvenile rats, ozenoxacin showed no chondrotoxicity, whereas ofloxacin produced typical quinolone-induced lesions in articular cartilage in three of ten rats. Oral ozenoxacin administration to juvenile dogs showed no chondrotoxicity or toxicologically relevant findings in selected target organs. Conclusion: Ozenoxacin was generally well-tolerated in juvenile rats and dogs, with no evidence of quinolone-induced arthropathy.

1 August 2002 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
JBJorge I.González Borroto
Jorge I.González Borroto
ACAmadeu Creus
Amadeu Creus
RMRicard Marcos
Ricard Marcos